Shalini Arunogiri

Professional Summary: Professor Shalini Arunogiri

Professor Shalini Arunogiri is a distinguished academic and clinician at Monash University, Australia, with a focus on addiction psychiatry and mental health. Her expertise bridges clinical practice and research, contributing significantly to the understanding and treatment of substance use disorders and co-occurring mental health conditions.

Academic Background and Degrees

Professor Arunogiri holds advanced qualifications in medicine and psychiatry. She is a Fellow of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) and has completed specialized training in addiction psychiatry.

Research Specializations and Academic Interests

Her research primarily focuses on addiction medicine, with specific interests in:

• Substance use disorders and dual diagnosis (co-occurring mental health conditions)
• Novel treatments for addiction, including pharmacological and psychosocial interventions
• Women’s mental health in the context of substance use
• Public health approaches to reducing harm from substance use

Career History and Appointments

Professor Arunogiri holds several key positions that reflect her leadership in the field:

• Associate Professor at the Department of Psychiatry, Monash University
• Clinical Director of the Turning Point Alcohol and Drug Centre, a leading addiction treatment and research organization in Australia
• Consultant Psychiatrist specializing in addiction psychiatry

Major Awards, Fellowships, and Honors

Professor Arunogiri has been recognized for her contributions to psychiatry and addiction research:

• Recipient of competitive research grants from organizations such as the National Health and Medical Research Council (NHMRC) in Australia
• Recognized for leadership in clinical innovation and education in addiction medicine

Key Publications

Professor Arunogiri has authored numerous peer-reviewed articles and reports in high-impact journals. Some notable publications include:

• Arunogiri, S., et al. (2021). "Challenges in managing alcohol withdrawal in patients with co-occurring disorders." Drug and Alcohol Review.
• Arunogiri, S., et al. (2018). "A systematic review of risk factors for methamphetamine-associated psychosis." Australian & New Zealand Journal of Psychiatry.
• Arunogiri, S., et al. (2019). "Management of borderline personality disorder in the context of substance use." Current Opinion in Psychiatry.

Influence and Impact on Academic Field

Professor Arunogiri’s work has had a profound impact on the field of addiction psychiatry, particularly in Australia. Her research on methamphetamine use and dual diagnosis has informed clinical guidelines and policy, improving treatment outcomes for vulnerable populations. As a leader at Turning Point, she has driven initiatives to translate research into practice, enhancing access to evidence-based care for substance use disorders. Her focus on women’s mental health in addiction contexts addresses critical gaps in the field.

Public Lectures, Committees, and Editorial Contributions

Professor Arunogiri is actively involved in academic and professional communities:

• Regular speaker at national and international conferences on addiction and mental health
• Member of advisory committees for addiction policy and treatment guidelines in Australia
• Contributor to editorial boards and peer review for journals in psychiatry and addiction medicine